Cancer Research Technology and Pangaea Biotech sign license agreement to develop new cancer drugs

by Pangaea Biotech

CANCER Research Technology (CRT), the development and commercialisation arm of Cancer Research UK – has entered into a license agreement with Pangaea Biotech to develop p21-activated kinase (PAK) in...

Read more

DiaCarta and Pangaea Biotech Join Forces to Launch Non-Invasive Tests to Detect Genetic Mutations in Blood from Cancer Patients

by Pangaea Biotech

This agreement gives Pangaea access to the experience of DiaCarta, a leader in development and commercialization of personalized diagnostic tools, while DiaCarta stands to benefit from that of an inte...

Read more
Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Palobiofarma announces the completion th...

by Palobiofarma

Palobiofarma S.L. is pleased to announce the “last patient last visi...

Photos Stream